Congress Park Capital LLC grew its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 3.3% during the fourth quarter, HoldingsChannel.com reports. The firm owned 1,085 shares of the healthcare conglomerate’s stock after buying an additional 35 shares during the period. Congress Park Capital LLC’s holdings in UnitedHealth Group were worth $549,000 at the end of the most recent quarter.
A number of other institutional investors have also made changes to their positions in UNH. Kathleen S. Wright Associates Inc. acquired a new position in shares of UnitedHealth Group during the 3rd quarter worth about $27,000. Global Wealth Strategies & Associates grew its holdings in UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 32 shares during the period. West Financial Advisors LLC acquired a new stake in UnitedHealth Group in the third quarter worth $32,000. RPg Family Wealth Advisory LLC acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at $37,000. Finally, Quarry LP raised its stake in UnitedHealth Group by 132.1% during the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after buying an additional 37 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
UNH has been the subject of several recent analyst reports. Deutsche Bank Aktiengesellschaft increased their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Royal Bank of Canada dropped their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday, October 16th. Morgan Stanley lowered their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. KeyCorp began coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $675.00 target price for the company. Finally, Truist Financial cut their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Two equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and three have issued a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Buy” and an average target price of $626.79.
UnitedHealth Group Trading Down 6.0 %
Shares of NYSE:UNH opened at $511.02 on Friday. The company has a 50-day simple moving average of $553.38 and a 200 day simple moving average of $562.98. The company has a market capitalization of $470.28 billion, a P/E ratio of 33.29, a price-to-earnings-growth ratio of 1.42 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73.
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the prior year, the business earned $5.83 EPS. The firm’s revenue for the quarter was up 6.8% on a year-over-year basis. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.64%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
- Five stocks we like better than UnitedHealth Group
- Why Invest in High-Yield Dividend Stocks?
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- Stock Splits, Do They Really Impact Investors?
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- What is the Euro STOXX 50 Index?
- Micron Technology: Riding the AI Wave to Long-Term Growth
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.